Table 2.
Evolution of weight and clinical parameters after side-to-side magnetic duodeno-ileostomy with sleeve gastrectomy
Baseline | 6-month follow-up (n = 24) |
12-month follow-up (n = 5) |
|||||
---|---|---|---|---|---|---|---|
Mean ± SEM | Mean ± SEM | Mean change ± SEM (95%CI) |
P-value | Mean ± SEM | Mean change ± SEM (95%CI) |
P-value | |
Weight | |||||||
Absolute wt, kg | 121.9 ± 3.3 | 87.8 ± 2.8 |
34.2 ± 1.6 (30.9, 37.4) |
< 0.001 | 77.6 ± 4.7 |
40.0 ± 3.1 (31.4, 48.6) |
< 0.001 |
BMI, kg/m2 | 44.4 ± 0.8 | 32.0 ± 0.8 |
12.4 ± 0.5 (11.5, 13.3) |
< 0.001 | 29.3 ± 1.5 |
15.1 ± 1.0 (12.2, 18.0) |
< 0.001 |
TWL, % | – | 28.1 ± 1.0 | – | – | 34.0 ± 1.4 | – | – |
EWL, % | – | 66.2 ± 3.4 | – | – | 80.2 ± 6.6 | – | – |
Clinical | |||||||
HbA1C, %* | 6.2 ± 0.3 | 5.1 ± 0.2 |
1.1 ± 0.4 (0.2, 1.9) |
< 0.05 | 4.8 ± 0.2 |
2.0 ± 1.1 –†† |
0.173 |
Glucose, mg/dL† | 111.3 ± 6.1 | 86.5 ± 3.5 |
24.8 ± 6.6 (11.0, 38.6) |
< 0.001 | 87.3 ± 6.3 |
53.8 ± 6.3 –†† |
0.113 |
BMI: Body mass index; TWL: Total weight loss; EWL: Excess weight loss; HbA1C: Glycosylated hemoglobin
*HbA1C baseline n = 20; 6-month n = 19; 12-month n = 4
†Glucose baseline n = 21; 6-month n = 21; 12-month n = 4
††Not applicable due to small sample size